MEETING IN THE MILLYARD
LIVE

Serial Number

50048574

Owner

Advanced Regenerative Manufacturing Institute

Attorney

Mark Tetreault

First Use Date

Apr 1, 2019

Filing Date

Aug 13, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MEETING IN THE MILLYARD Trademark

Serial Number: 50048574

MEETING IN THE MILLYARD is a trademark filed by Advanced Regenerative Manufacturing Institute on August 13, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Advanced Regenerative Manufacturing Institute (14 trademarks)

400 Commercial Street
Manchester, NH 03101

Entity Type: 03

Trademark Details

Filing Date

August 13, 2026

Registration Date

Not Registered

First Use Anywhere

April 1, 2019

First Use in Commerce

April 1, 2019

Goods & Services

Arranging and conducting of conferences and symposia in the field of medical science; Educational services, namely, providing conducting classes, seminars, conferences, workshops and fieldtrips in the fields of medical science

Conducting an on-line trade show exhibition, in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; Promoting and conducting trade shows in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; Providing career information in the field of science, technology, engineering and mathematics, tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets; Promoting education in the science, technology, engineering, and mathematics (STEM) field; Business consultancy relating to risk and regulatory compliance management; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 13, 2026 MAFR
NEW APPLICATION ENTERED
Aug 13, 2026 NWAP